跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Maxibustat 40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Maxibustat 40
Approved
STANDARD
Maxibustat 40
Sunrise International Labs Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
96a17b3148e0c87a
Company
Sunrise International Labs Limited
Type
Standard
Approval Details
Approval Id
96a17b3148e0c87a
Drug Approval Philippines Name
Maxibustat 40
Product Name
Maxibustat 40
Registration Number
DRP-12601-02
Brand Name
Maxibustat 40
Generic Name
Febuxostat
Dosage Form
Film-Coated Tablet
Dosage Strength
40 mg
Manufacturer
Sunrise International Labs Limited
Importer
Bliss Pharma Distribution and Consultancy Corp
Distributor
Afree Pharmaceutical Distribution Corp
Issuance Date
26 October 2022
Expiry Date
14 September 2027
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
96a17b3148e0c87a
Type
Standard
Back to Philippines FDA Approvals